Mohseni, Rashin
Mahdavi Sharif, Pouya
Behfar, Maryam
Modaresi, Mohammad Reza
Shirzadi, Rohola
Mardani, Mahta
Jafari, Leila
Jafari, Fahimeh
Nikfetrat, Zeynab
Hamidieh, Amir Ali http://orcid.org/0000-0002-8935-079X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)
https://doi.org/10.1186/s13287-023-03498-y
Funding for this research was provided by:
National Council for Development of Stem Cell Sciences and Technologies
Article History
Received: 6 August 2023
Accepted: 13 September 2023
First Online: 19 September 2023
Declarations
:
: This study (<i>Evaluation of Safety and Effectiveness of Allogeneic Adipose-Derived Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome (BoS) after Allogeneic Hematopoietic Stem Cell Transplantation</i>) is approved by the ethics committee of the Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1399.406) on 5 September 2020. All of our included cases’ parents and donors of AT-MSCs were asked to complete and sign the written informed consent forms before participation in the study.
: The parents of included cases have consented to the anonymous publication of their children’s data.
: The authors declare that they have no competing interests.